ArticleAmerican journal of translational research2023

Effectiveness and safety of mono-anlotinib mono therapy or in combination with chemotherapy in platinum-resistant recurrent ovarian cancer: a single-center retrospective study.

Yue Wu et al.PubMed ↗Full text ↗

No numbers read from the abstract.